PhRMA firms' “record 313 mental illness drugs now in R&D” Pharma Times Other potential medicines target attention-deficit/hyperactivity disorder, autism, eating disorders, personality disorders, premenstrual disorders and sleep ... et plus encore »

Opposing Views

Should teachers be able to tell parents their child needs to be checked for ... Helium As mentioned, it's not a good idea for an educator to state directly that a child needs to be tested for ADD or Attention Deficit Hyperactivity Disorder ... Does the cortisol response to stress mediate the link between expressed ...7thSpace Interactive (press release) If Teacher Suspects Student has ADHD, Should He Tell Parents?Opposing Views all 3 news articles »

Intellipharmaceutics Announces Second Quarter 2010 Results MarketWatch (press release) ... version of the Attention Deficit Hyperactivity Disorder drug Focalin XR(R) (dexmethylphenidate hydrochloride), subject to regulatory and court approval. ... and more »

THE COLONY — Last January, nine-year-old Montana Lance took his own life in a school bathroom. Since that day, many have searched for the answer to one question' Why? It's a question that may never be answered, but the youngster's family can't help but wonder if a drug he was taking for Attention-Deficit Hyperactivity Disorder (ADHD) had something to do with it. The prescription drug is called ...

FDA Approves ADHD Daytrana Patch for Use in Teens DrugWatch.com ... (FDA) approval of Daytrana (methylphenidate) for the treatment of attention deficit hyperactivity disorder (ADHD) in adolescents aged 13 to 17. ... and more »